![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 38/43 | (2006.01) |
A61P 3/06 | (2006.01) |
(11) | Number of the document | 2470199 |
(13) | Kind of document | T |
(96) | European patent application number | 10812683.0 |
Date of filing the European patent application | 2010-08-28 | |
(97) | Date of publication of the European application | 2012-07-04 |
(45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
(46) | Date of publication of the claims translation | 2019-10-10 |
(86) | Number | PCT/US2010/047057 |
Date | 2010-08-28 |
(87) | Number | WO 2011/025996 |
Date | 2011-03-03 |
(30) | Number | Date | Country code |
238113 P | 2009-08-28 | US |
(72) |
SCHUCHMAN, Edward, H., US
DESNICK, Robert, J., US
COX, Gerald, F., US
ANDREWS, Laura, P., US
MURRAY, James, M., US
|
(73) |
Icahn School of Medicine at Mount Sinai,
One Gustave L. Levy Place, New York, NY 10029,
US
Genzyme Corporation, 50 Binney Street, Cambridge, MA 02142, US |
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pakaitinė fermento terapija su dozės didinimu, skirta rūgštinės sfingomielinazės nepakankamumo gydymui |
DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY |
Payment date | Validity (years) | Amount | |
2025-07-31 | 16 | 347.00 EUR |
2026-08-28 |